Index by author
February 01, 2004; Volume 32,Issue 2
A
Achanfuo-Yeboah, Joana
- You have accessIDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF POSACONAZOLE (NOXAFIL)Anima Ghosal, Neil Hapangama, Yuan Yuan, Joana Achanfuo-Yeboah, Robert Iannucci, Swapan Chowdhury, Kevin Alton, James E. Patrick and Shmuel ZbaidaDrug Metabolism and Disposition February 2004, 32 (2) 267-271; DOI: https://doi.org/10.1124/dmd.32.2.267
Alton, Kevin
- You have accessIDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF POSACONAZOLE (NOXAFIL)Anima Ghosal, Neil Hapangama, Yuan Yuan, Joana Achanfuo-Yeboah, Robert Iannucci, Swapan Chowdhury, Kevin Alton, James E. Patrick and Shmuel ZbaidaDrug Metabolism and Disposition February 2004, 32 (2) 267-271; DOI: https://doi.org/10.1124/dmd.32.2.267
Anari, Reza
- You have accessTHE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGSSu-Er W. Huskey, Brian J. Dean, George A. Doss, Zhen Wang, Cornelis E.C.A. Hop, Reza Anari, Paul E. Finke, Albert J. Robichaud, Minghua Zhang, Bonnie Wang, John R. Strauss, Paul K. Cunningham, William P. Feeney, Ronald B. Franklin, Thomas A. Baillie and Shuet-Hing L. ChiuDrug Metabolism and Disposition February 2004, 32 (2) 246-258; DOI: https://doi.org/10.1124/dmd.32.2.246
Ando, Masanori
- You have accessINVOLVEMENT OF HUMAN HEPATIC UGT1A1, UGT2B4, AND UGT2B7 IN THE GLUCURONIDATION OF CARVEDILOLAkiko Ohno, Yoshiro Saito, Nobumitsu Hanioka, Hideto Jinno, Mayumi Saeki, Masanori Ando, Shogo Ozawa and Jun-ichi SawadaDrug Metabolism and Disposition February 2004, 32 (2) 235-239; DOI: https://doi.org/10.1124/dmd.32.2.235
Asai, Akira
- You have accessBIOTRANSFORMATION OF FUCOXANTHINOL INTO AMAROUCIAXANTHIN A IN MICE AND HEPG2 CELLS: FORMATION AND CYTOTOXICITY OF FUCOXANTHIN METABOLITESAkira Asai, Tatsuya Sugawara, Hiroshi Ono and Akihiko NagaoDrug Metabolism and Disposition February 2004, 32 (2) 205-211; DOI: https://doi.org/10.1124/dmd.32.2.205
Azzarano, Leonard M.
- You have accessDEVELOPMENT OF AN IN VIVO PRECLINICAL SCREEN MODEL TO ESTIMATE ABSORPTION AND FIRST-PASS HEPATIC EXTRACTION OF XENOBIOTICS. II. USE OF KETOCONAZOLE TO IDENTIFY P-GLYCOPROTEIN/CYP3A-LIMITED BIOAVAILABILITY IN THE MONKEYKeith W. Ward, Gary J. Stelman, Jayme A. Morgan, Kelli S. Zeigler, Leonard M. Azzarano, Jonathan R. Kehler, Jeanelle E. McSurdy-Freed, Joel W. Proksch and Brian R. SmithDrug Metabolism and Disposition February 2004, 32 (2) 172-177; DOI: https://doi.org/10.1124/dmd.32.2.172
B
Baillie, Thomas A.
- You have accessTHE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGSSu-Er W. Huskey, Brian J. Dean, George A. Doss, Zhen Wang, Cornelis E.C.A. Hop, Reza Anari, Paul E. Finke, Albert J. Robichaud, Minghua Zhang, Bonnie Wang, John R. Strauss, Paul K. Cunningham, William P. Feeney, Ronald B. Franklin, Thomas A. Baillie and Shuet-Hing L. ChiuDrug Metabolism and Disposition February 2004, 32 (2) 246-258; DOI: https://doi.org/10.1124/dmd.32.2.246
Beaumont, Kevin
- You have accessNONLINEAR ORAL PHARMACOKINETICS OF THE α-ANTAGONIST 4-AMINO-5-(4-FLUOROPHENYL)-6,7-DIMETHOXY-2-[4-(MORPHOLINOCARBONYL)-PERHYDRO-1,4-DIAZEPIN-1-YL]QUINOLINE IN HUMANS: USE OF PRECLINICAL DATA TO RATIONALIZE CLINICAL OBSERVATIONSAnthony Harrison, Alison Betts, Katherine Fenner, Kevin Beaumont, Alan Edgington, Sarah Roffey, John Davis, Pierre Comby and Paul MorganDrug Metabolism and Disposition February 2004, 32 (2) 197-204; DOI: https://doi.org/10.1124/dmd.32.2.197
Betts, Alison
- You have accessNONLINEAR ORAL PHARMACOKINETICS OF THE α-ANTAGONIST 4-AMINO-5-(4-FLUOROPHENYL)-6,7-DIMETHOXY-2-[4-(MORPHOLINOCARBONYL)-PERHYDRO-1,4-DIAZEPIN-1-YL]QUINOLINE IN HUMANS: USE OF PRECLINICAL DATA TO RATIONALIZE CLINICAL OBSERVATIONSAnthony Harrison, Alison Betts, Katherine Fenner, Kevin Beaumont, Alan Edgington, Sarah Roffey, John Davis, Pierre Comby and Paul MorganDrug Metabolism and Disposition February 2004, 32 (2) 197-204; DOI: https://doi.org/10.1124/dmd.32.2.197
Bonhomme-Faivre, Laurence
- You have accessEFFECT OF RECOMBINANT INTERLEUKIN-2 PRETREATMENT ON ORAL AND INTRAVENOUS DIGOXIN PHARMACOKINETICS AND P-GLYCOPROTEIN ACTIVITY IN MICEVincent Castagne, Laurence Bonhomme-Faivre, Saik Urien, Makram Ben Reguiga, Mireille Soursac, Francois Gimenez and Robert FarinottiDrug Metabolism and Disposition February 2004, 32 (2) 168-171; DOI: https://doi.org/10.1124/dmd.32.2.168
C
Cashman, John R.
- You have accessEFFECT OF TOTAL PARENTERAL NUTRITION AND CHOLINE ON HEPATIC FLAVIN-CONTAINING AND CYTOCHROME P-450 MONOOXYGENASE ACTIVITY IN RATSJohn R. Cashman, Virginie Lattard and Jing LinDrug Metabolism and Disposition February 2004, 32 (2) 222-229; DOI: https://doi.org/10.1124/dmd.32.2.222
Castagne, Vincent
- You have accessEFFECT OF RECOMBINANT INTERLEUKIN-2 PRETREATMENT ON ORAL AND INTRAVENOUS DIGOXIN PHARMACOKINETICS AND P-GLYCOPROTEIN ACTIVITY IN MICEVincent Castagne, Laurence Bonhomme-Faivre, Saik Urien, Makram Ben Reguiga, Mireille Soursac, Francois Gimenez and Robert FarinottiDrug Metabolism and Disposition February 2004, 32 (2) 168-171; DOI: https://doi.org/10.1124/dmd.32.2.168
Chadwick, Lucas R.
- You have accessMETABOLISM OF 8-PRENYLNARINGENIN, A POTENT PHYTOESTROGEN FROM HOPS (HUMULUS LUPULUS), BY HUMAN LIVER MICROSOMESDejan Nikolic, Yongmei Li, Lucas R. Chadwick, Simonida Grubjesic, Pia Schwab, Peter Metz and Richard B. van BreemenDrug Metabolism and Disposition February 2004, 32 (2) 272-279; DOI: https://doi.org/10.1124/dmd.32.2.272
Chiu, Shuet-Hing L.
- You have accessTHE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGSSu-Er W. Huskey, Brian J. Dean, George A. Doss, Zhen Wang, Cornelis E.C.A. Hop, Reza Anari, Paul E. Finke, Albert J. Robichaud, Minghua Zhang, Bonnie Wang, John R. Strauss, Paul K. Cunningham, William P. Feeney, Ronald B. Franklin, Thomas A. Baillie and Shuet-Hing L. ChiuDrug Metabolism and Disposition February 2004, 32 (2) 246-258; DOI: https://doi.org/10.1124/dmd.32.2.246
Chowdhury, Swapan
- You have accessIDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF POSACONAZOLE (NOXAFIL)Anima Ghosal, Neil Hapangama, Yuan Yuan, Joana Achanfuo-Yeboah, Robert Iannucci, Swapan Chowdhury, Kevin Alton, James E. Patrick and Shmuel ZbaidaDrug Metabolism and Disposition February 2004, 32 (2) 267-271; DOI: https://doi.org/10.1124/dmd.32.2.267
Coffee, Richard
- You have accessDIFFERENTIAL REGULATION OF THE HUMAN CYP3A4 PROMOTER IN TRANSGENIC MICE AND RATSWeisheng Zhang, Anthony F. Purchio, Richard Coffee and David B. WestDrug Metabolism and Disposition February 2004, 32 (2) 163-167; DOI: https://doi.org/10.1124/dmd.32.2.163
Comby, Pierre
- You have accessNONLINEAR ORAL PHARMACOKINETICS OF THE α-ANTAGONIST 4-AMINO-5-(4-FLUOROPHENYL)-6,7-DIMETHOXY-2-[4-(MORPHOLINOCARBONYL)-PERHYDRO-1,4-DIAZEPIN-1-YL]QUINOLINE IN HUMANS: USE OF PRECLINICAL DATA TO RATIONALIZE CLINICAL OBSERVATIONSAnthony Harrison, Alison Betts, Katherine Fenner, Kevin Beaumont, Alan Edgington, Sarah Roffey, John Davis, Pierre Comby and Paul MorganDrug Metabolism and Disposition February 2004, 32 (2) 197-204; DOI: https://doi.org/10.1124/dmd.32.2.197
Cook, Chyung S.
- You have accessDIFFERENTIAL ENANTIOSELECTIVITY AND PRODUCT-DEPENDENT ACTIVATION AND INHIBITION IN METABOLISM OF VERAPAMIL BY HUMAN CYP3ASLixin Shen, John F. Fitzloff and Chyung S. CookDrug Metabolism and Disposition February 2004, 32 (2) 186-196; DOI: https://doi.org/10.1124/dmd.32.2.186
Cunningham, Paul K.
- You have accessTHE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGSSu-Er W. Huskey, Brian J. Dean, George A. Doss, Zhen Wang, Cornelis E.C.A. Hop, Reza Anari, Paul E. Finke, Albert J. Robichaud, Minghua Zhang, Bonnie Wang, John R. Strauss, Paul K. Cunningham, William P. Feeney, Ronald B. Franklin, Thomas A. Baillie and Shuet-Hing L. ChiuDrug Metabolism and Disposition February 2004, 32 (2) 246-258; DOI: https://doi.org/10.1124/dmd.32.2.246
D
Davis, John
- You have accessNONLINEAR ORAL PHARMACOKINETICS OF THE α-ANTAGONIST 4-AMINO-5-(4-FLUOROPHENYL)-6,7-DIMETHOXY-2-[4-(MORPHOLINOCARBONYL)-PERHYDRO-1,4-DIAZEPIN-1-YL]QUINOLINE IN HUMANS: USE OF PRECLINICAL DATA TO RATIONALIZE CLINICAL OBSERVATIONSAnthony Harrison, Alison Betts, Katherine Fenner, Kevin Beaumont, Alan Edgington, Sarah Roffey, John Davis, Pierre Comby and Paul MorganDrug Metabolism and Disposition February 2004, 32 (2) 197-204; DOI: https://doi.org/10.1124/dmd.32.2.197
Dean, Brian J.
- You have accessTHE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGSSu-Er W. Huskey, Brian J. Dean, George A. Doss, Zhen Wang, Cornelis E.C.A. Hop, Reza Anari, Paul E. Finke, Albert J. Robichaud, Minghua Zhang, Bonnie Wang, John R. Strauss, Paul K. Cunningham, William P. Feeney, Ronald B. Franklin, Thomas A. Baillie and Shuet-Hing L. ChiuDrug Metabolism and Disposition February 2004, 32 (2) 246-258; DOI: https://doi.org/10.1124/dmd.32.2.246
Doss, George A.
- You have accessIDENTIFICATION OF A HYDROXYLAMINE GLUCURONIDE METABOLITE OF AN ORAL HYPOGLYCEMIC AGENTRandall R. Miller, George A. Doss and Ralph A. StearnsDrug Metabolism and Disposition February 2004, 32 (2) 178-185; DOI: https://doi.org/10.1124/dmd.32.2.178
- You have accessTHE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGSSu-Er W. Huskey, Brian J. Dean, George A. Doss, Zhen Wang, Cornelis E.C.A. Hop, Reza Anari, Paul E. Finke, Albert J. Robichaud, Minghua Zhang, Bonnie Wang, John R. Strauss, Paul K. Cunningham, William P. Feeney, Ronald B. Franklin, Thomas A. Baillie and Shuet-Hing L. ChiuDrug Metabolism and Disposition February 2004, 32 (2) 246-258; DOI: https://doi.org/10.1124/dmd.32.2.246
E
Edgington, Alan
- You have accessNONLINEAR ORAL PHARMACOKINETICS OF THE α-ANTAGONIST 4-AMINO-5-(4-FLUOROPHENYL)-6,7-DIMETHOXY-2-[4-(MORPHOLINOCARBONYL)-PERHYDRO-1,4-DIAZEPIN-1-YL]QUINOLINE IN HUMANS: USE OF PRECLINICAL DATA TO RATIONALIZE CLINICAL OBSERVATIONSAnthony Harrison, Alison Betts, Katherine Fenner, Kevin Beaumont, Alan Edgington, Sarah Roffey, John Davis, Pierre Comby and Paul MorganDrug Metabolism and Disposition February 2004, 32 (2) 197-204; DOI: https://doi.org/10.1124/dmd.32.2.197
F
Farinotti, Robert
- You have accessEFFECT OF RECOMBINANT INTERLEUKIN-2 PRETREATMENT ON ORAL AND INTRAVENOUS DIGOXIN PHARMACOKINETICS AND P-GLYCOPROTEIN ACTIVITY IN MICEVincent Castagne, Laurence Bonhomme-Faivre, Saik Urien, Makram Ben Reguiga, Mireille Soursac, Francois Gimenez and Robert FarinottiDrug Metabolism and Disposition February 2004, 32 (2) 168-171; DOI: https://doi.org/10.1124/dmd.32.2.168
Feeney, William P.
- You have accessTHE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGSSu-Er W. Huskey, Brian J. Dean, George A. Doss, Zhen Wang, Cornelis E.C.A. Hop, Reza Anari, Paul E. Finke, Albert J. Robichaud, Minghua Zhang, Bonnie Wang, John R. Strauss, Paul K. Cunningham, William P. Feeney, Ronald B. Franklin, Thomas A. Baillie and Shuet-Hing L. ChiuDrug Metabolism and Disposition February 2004, 32 (2) 246-258; DOI: https://doi.org/10.1124/dmd.32.2.246
Fenner, Katherine
- You have accessNONLINEAR ORAL PHARMACOKINETICS OF THE α-ANTAGONIST 4-AMINO-5-(4-FLUOROPHENYL)-6,7-DIMETHOXY-2-[4-(MORPHOLINOCARBONYL)-PERHYDRO-1,4-DIAZEPIN-1-YL]QUINOLINE IN HUMANS: USE OF PRECLINICAL DATA TO RATIONALIZE CLINICAL OBSERVATIONSAnthony Harrison, Alison Betts, Katherine Fenner, Kevin Beaumont, Alan Edgington, Sarah Roffey, John Davis, Pierre Comby and Paul MorganDrug Metabolism and Disposition February 2004, 32 (2) 197-204; DOI: https://doi.org/10.1124/dmd.32.2.197
Finke, Paul E.
- You have accessTHE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGSSu-Er W. Huskey, Brian J. Dean, George A. Doss, Zhen Wang, Cornelis E.C.A. Hop, Reza Anari, Paul E. Finke, Albert J. Robichaud, Minghua Zhang, Bonnie Wang, John R. Strauss, Paul K. Cunningham, William P. Feeney, Ronald B. Franklin, Thomas A. Baillie and Shuet-Hing L. ChiuDrug Metabolism and Disposition February 2004, 32 (2) 246-258; DOI: https://doi.org/10.1124/dmd.32.2.246
Fitzloff, John F.
- You have accessDIFFERENTIAL ENANTIOSELECTIVITY AND PRODUCT-DEPENDENT ACTIVATION AND INHIBITION IN METABOLISM OF VERAPAMIL BY HUMAN CYP3ASLixin Shen, John F. Fitzloff and Chyung S. CookDrug Metabolism and Disposition February 2004, 32 (2) 186-196; DOI: https://doi.org/10.1124/dmd.32.2.186
Franklin, Ronald B.
- You have accessTHE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGSSu-Er W. Huskey, Brian J. Dean, George A. Doss, Zhen Wang, Cornelis E.C.A. Hop, Reza Anari, Paul E. Finke, Albert J. Robichaud, Minghua Zhang, Bonnie Wang, John R. Strauss, Paul K. Cunningham, William P. Feeney, Ronald B. Franklin, Thomas A. Baillie and Shuet-Hing L. ChiuDrug Metabolism and Disposition February 2004, 32 (2) 246-258; DOI: https://doi.org/10.1124/dmd.32.2.246
Fujii, Toshihiko
- You have accessPOLYMORPHIC EXPRESSION OF CYP1A2 LEADING TO INTERINDIVIDUAL VARIABILITY IN METABOLISM OF A NOVEL BENZODIAZEPINE RECEPTOR PARTIAL INVERSE AGONIST IN DOGSMasashi Mise, Seiji Yadera, Michiaki Matsuda, Takanori Hashizume, Satoshi Matsumoto, Yoshiaki Terauchi and Toshihiko FujiiDrug Metabolism and Disposition February 2004, 32 (2) 240-245; DOI: https://doi.org/10.1124/dmd.32.2.240
G
Ghosal, Anima
- You have accessIDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF POSACONAZOLE (NOXAFIL)Anima Ghosal, Neil Hapangama, Yuan Yuan, Joana Achanfuo-Yeboah, Robert Iannucci, Swapan Chowdhury, Kevin Alton, James E. Patrick and Shmuel ZbaidaDrug Metabolism and Disposition February 2004, 32 (2) 267-271; DOI: https://doi.org/10.1124/dmd.32.2.267
Gimenez, Francois
- You have accessEFFECT OF RECOMBINANT INTERLEUKIN-2 PRETREATMENT ON ORAL AND INTRAVENOUS DIGOXIN PHARMACOKINETICS AND P-GLYCOPROTEIN ACTIVITY IN MICEVincent Castagne, Laurence Bonhomme-Faivre, Saik Urien, Makram Ben Reguiga, Mireille Soursac, Francois Gimenez and Robert FarinottiDrug Metabolism and Disposition February 2004, 32 (2) 168-171; DOI: https://doi.org/10.1124/dmd.32.2.168
Grubjesic, Simonida
- You have accessMETABOLISM OF 8-PRENYLNARINGENIN, A POTENT PHYTOESTROGEN FROM HOPS (HUMULUS LUPULUS), BY HUMAN LIVER MICROSOMESDejan Nikolic, Yongmei Li, Lucas R. Chadwick, Simonida Grubjesic, Pia Schwab, Peter Metz and Richard B. van BreemenDrug Metabolism and Disposition February 2004, 32 (2) 272-279; DOI: https://doi.org/10.1124/dmd.32.2.272
H
Hall, Stephen D.
- You have accessPREDICTION OF CYTOCHROME P450 3A INHIBITION BY VERAPAMIL ENANTIOMERS AND THEIR METABOLITESYing-Hong Wang, David R. Jones and Stephen D. HallDrug Metabolism and Disposition February 2004, 32 (2) 259-266; DOI: https://doi.org/10.1124/dmd.32.2.259
Hanioka, Nobumitsu
- You have accessINVOLVEMENT OF HUMAN HEPATIC UGT1A1, UGT2B4, AND UGT2B7 IN THE GLUCURONIDATION OF CARVEDILOLAkiko Ohno, Yoshiro Saito, Nobumitsu Hanioka, Hideto Jinno, Mayumi Saeki, Masanori Ando, Shogo Ozawa and Jun-ichi SawadaDrug Metabolism and Disposition February 2004, 32 (2) 235-239; DOI: https://doi.org/10.1124/dmd.32.2.235
Hapangama, Neil
- You have accessIDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF POSACONAZOLE (NOXAFIL)Anima Ghosal, Neil Hapangama, Yuan Yuan, Joana Achanfuo-Yeboah, Robert Iannucci, Swapan Chowdhury, Kevin Alton, James E. Patrick and Shmuel ZbaidaDrug Metabolism and Disposition February 2004, 32 (2) 267-271; DOI: https://doi.org/10.1124/dmd.32.2.267
Harrison, Anthony
- You have accessNONLINEAR ORAL PHARMACOKINETICS OF THE α-ANTAGONIST 4-AMINO-5-(4-FLUOROPHENYL)-6,7-DIMETHOXY-2-[4-(MORPHOLINOCARBONYL)-PERHYDRO-1,4-DIAZEPIN-1-YL]QUINOLINE IN HUMANS: USE OF PRECLINICAL DATA TO RATIONALIZE CLINICAL OBSERVATIONSAnthony Harrison, Alison Betts, Katherine Fenner, Kevin Beaumont, Alan Edgington, Sarah Roffey, John Davis, Pierre Comby and Paul MorganDrug Metabolism and Disposition February 2004, 32 (2) 197-204; DOI: https://doi.org/10.1124/dmd.32.2.197
Hashizume, Takanori
- You have accessPOLYMORPHIC EXPRESSION OF CYP1A2 LEADING TO INTERINDIVIDUAL VARIABILITY IN METABOLISM OF A NOVEL BENZODIAZEPINE RECEPTOR PARTIAL INVERSE AGONIST IN DOGSMasashi Mise, Seiji Yadera, Michiaki Matsuda, Takanori Hashizume, Satoshi Matsumoto, Yoshiaki Terauchi and Toshihiko FujiiDrug Metabolism and Disposition February 2004, 32 (2) 240-245; DOI: https://doi.org/10.1124/dmd.32.2.240
Hop, Cornelis E.C.A.
- You have accessTHE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGSSu-Er W. Huskey, Brian J. Dean, George A. Doss, Zhen Wang, Cornelis E.C.A. Hop, Reza Anari, Paul E. Finke, Albert J. Robichaud, Minghua Zhang, Bonnie Wang, John R. Strauss, Paul K. Cunningham, William P. Feeney, Ronald B. Franklin, Thomas A. Baillie and Shuet-Hing L. ChiuDrug Metabolism and Disposition February 2004, 32 (2) 246-258; DOI: https://doi.org/10.1124/dmd.32.2.246
Huskey, Su-Er W.
- You have accessTHE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGSSu-Er W. Huskey, Brian J. Dean, George A. Doss, Zhen Wang, Cornelis E.C.A. Hop, Reza Anari, Paul E. Finke, Albert J. Robichaud, Minghua Zhang, Bonnie Wang, John R. Strauss, Paul K. Cunningham, William P. Feeney, Ronald B. Franklin, Thomas A. Baillie and Shuet-Hing L. ChiuDrug Metabolism and Disposition February 2004, 32 (2) 246-258; DOI: https://doi.org/10.1124/dmd.32.2.246
I
Iannucci, Robert
- You have accessIDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF POSACONAZOLE (NOXAFIL)Anima Ghosal, Neil Hapangama, Yuan Yuan, Joana Achanfuo-Yeboah, Robert Iannucci, Swapan Chowdhury, Kevin Alton, James E. Patrick and Shmuel ZbaidaDrug Metabolism and Disposition February 2004, 32 (2) 267-271; DOI: https://doi.org/10.1124/dmd.32.2.267
J
Jinno, Hideto
- You have accessINVOLVEMENT OF HUMAN HEPATIC UGT1A1, UGT2B4, AND UGT2B7 IN THE GLUCURONIDATION OF CARVEDILOLAkiko Ohno, Yoshiro Saito, Nobumitsu Hanioka, Hideto Jinno, Mayumi Saeki, Masanori Ando, Shogo Ozawa and Jun-ichi SawadaDrug Metabolism and Disposition February 2004, 32 (2) 235-239; DOI: https://doi.org/10.1124/dmd.32.2.235
Jones, David R.
- You have accessPREDICTION OF CYTOCHROME P450 3A INHIBITION BY VERAPAMIL ENANTIOMERS AND THEIR METABOLITESYing-Hong Wang, David R. Jones and Stephen D. HallDrug Metabolism and Disposition February 2004, 32 (2) 259-266; DOI: https://doi.org/10.1124/dmd.32.2.259
K
Kato, Takako
- You have accessAN EVALUATION METHOD FOR NONLINEAR LOCAL DISPOSITION IN RAT LIVER AND KIDNEYTakako Kato, Kiyoshi Yamaoka and Yoshinobu TakakuraDrug Metabolism and Disposition February 2004, 32 (2) 230-234; DOI: https://doi.org/10.1124/dmd.32.2.230
Kehler, Jonathan R.
- You have accessDEVELOPMENT OF AN IN VIVO PRECLINICAL SCREEN MODEL TO ESTIMATE ABSORPTION AND FIRST-PASS HEPATIC EXTRACTION OF XENOBIOTICS. II. USE OF KETOCONAZOLE TO IDENTIFY P-GLYCOPROTEIN/CYP3A-LIMITED BIOAVAILABILITY IN THE MONKEYKeith W. Ward, Gary J. Stelman, Jayme A. Morgan, Kelli S. Zeigler, Leonard M. Azzarano, Jonathan R. Kehler, Jeanelle E. McSurdy-Freed, Joel W. Proksch and Brian R. SmithDrug Metabolism and Disposition February 2004, 32 (2) 172-177; DOI: https://doi.org/10.1124/dmd.32.2.172
Kim, John
- You have accessSTEREOSELECTIVE PHARMACOKINETICS OF FLUOXETINE AND NORFLUOXETINE ENANTIOMERS IN PREGNANT SHEEPJohn Kim, K. Wayne Riggs and Dan W. RurakDrug Metabolism and Disposition February 2004, 32 (2) 212-221; DOI: https://doi.org/10.1124/dmd.32.2.212
L
Lattard, Virginie
- You have accessEFFECT OF TOTAL PARENTERAL NUTRITION AND CHOLINE ON HEPATIC FLAVIN-CONTAINING AND CYTOCHROME P-450 MONOOXYGENASE ACTIVITY IN RATSJohn R. Cashman, Virginie Lattard and Jing LinDrug Metabolism and Disposition February 2004, 32 (2) 222-229; DOI: https://doi.org/10.1124/dmd.32.2.222
Li, Yongmei
- You have accessMETABOLISM OF 8-PRENYLNARINGENIN, A POTENT PHYTOESTROGEN FROM HOPS (HUMULUS LUPULUS), BY HUMAN LIVER MICROSOMESDejan Nikolic, Yongmei Li, Lucas R. Chadwick, Simonida Grubjesic, Pia Schwab, Peter Metz and Richard B. van BreemenDrug Metabolism and Disposition February 2004, 32 (2) 272-279; DOI: https://doi.org/10.1124/dmd.32.2.272
Lin, Jing
- You have accessEFFECT OF TOTAL PARENTERAL NUTRITION AND CHOLINE ON HEPATIC FLAVIN-CONTAINING AND CYTOCHROME P-450 MONOOXYGENASE ACTIVITY IN RATSJohn R. Cashman, Virginie Lattard and Jing LinDrug Metabolism and Disposition February 2004, 32 (2) 222-229; DOI: https://doi.org/10.1124/dmd.32.2.222
M
Matsuda, Michiaki
- You have accessPOLYMORPHIC EXPRESSION OF CYP1A2 LEADING TO INTERINDIVIDUAL VARIABILITY IN METABOLISM OF A NOVEL BENZODIAZEPINE RECEPTOR PARTIAL INVERSE AGONIST IN DOGSMasashi Mise, Seiji Yadera, Michiaki Matsuda, Takanori Hashizume, Satoshi Matsumoto, Yoshiaki Terauchi and Toshihiko FujiiDrug Metabolism and Disposition February 2004, 32 (2) 240-245; DOI: https://doi.org/10.1124/dmd.32.2.240
Matsumoto, Satoshi
- You have accessPOLYMORPHIC EXPRESSION OF CYP1A2 LEADING TO INTERINDIVIDUAL VARIABILITY IN METABOLISM OF A NOVEL BENZODIAZEPINE RECEPTOR PARTIAL INVERSE AGONIST IN DOGSMasashi Mise, Seiji Yadera, Michiaki Matsuda, Takanori Hashizume, Satoshi Matsumoto, Yoshiaki Terauchi and Toshihiko FujiiDrug Metabolism and Disposition February 2004, 32 (2) 240-245; DOI: https://doi.org/10.1124/dmd.32.2.240
McSurdy-Freed, Jeanelle E.
- You have accessDEVELOPMENT OF AN IN VIVO PRECLINICAL SCREEN MODEL TO ESTIMATE ABSORPTION AND FIRST-PASS HEPATIC EXTRACTION OF XENOBIOTICS. II. USE OF KETOCONAZOLE TO IDENTIFY P-GLYCOPROTEIN/CYP3A-LIMITED BIOAVAILABILITY IN THE MONKEYKeith W. Ward, Gary J. Stelman, Jayme A. Morgan, Kelli S. Zeigler, Leonard M. Azzarano, Jonathan R. Kehler, Jeanelle E. McSurdy-Freed, Joel W. Proksch and Brian R. SmithDrug Metabolism and Disposition February 2004, 32 (2) 172-177; DOI: https://doi.org/10.1124/dmd.32.2.172
Metz, Peter
- You have accessMETABOLISM OF 8-PRENYLNARINGENIN, A POTENT PHYTOESTROGEN FROM HOPS (HUMULUS LUPULUS), BY HUMAN LIVER MICROSOMESDejan Nikolic, Yongmei Li, Lucas R. Chadwick, Simonida Grubjesic, Pia Schwab, Peter Metz and Richard B. van BreemenDrug Metabolism and Disposition February 2004, 32 (2) 272-279; DOI: https://doi.org/10.1124/dmd.32.2.272
Miller, Randall R.
- You have accessIDENTIFICATION OF A HYDROXYLAMINE GLUCURONIDE METABOLITE OF AN ORAL HYPOGLYCEMIC AGENTRandall R. Miller, George A. Doss and Ralph A. StearnsDrug Metabolism and Disposition February 2004, 32 (2) 178-185; DOI: https://doi.org/10.1124/dmd.32.2.178
Mise, Masashi
- You have accessPOLYMORPHIC EXPRESSION OF CYP1A2 LEADING TO INTERINDIVIDUAL VARIABILITY IN METABOLISM OF A NOVEL BENZODIAZEPINE RECEPTOR PARTIAL INVERSE AGONIST IN DOGSMasashi Mise, Seiji Yadera, Michiaki Matsuda, Takanori Hashizume, Satoshi Matsumoto, Yoshiaki Terauchi and Toshihiko FujiiDrug Metabolism and Disposition February 2004, 32 (2) 240-245; DOI: https://doi.org/10.1124/dmd.32.2.240
Morgan, Jayme A.
- You have accessDEVELOPMENT OF AN IN VIVO PRECLINICAL SCREEN MODEL TO ESTIMATE ABSORPTION AND FIRST-PASS HEPATIC EXTRACTION OF XENOBIOTICS. II. USE OF KETOCONAZOLE TO IDENTIFY P-GLYCOPROTEIN/CYP3A-LIMITED BIOAVAILABILITY IN THE MONKEYKeith W. Ward, Gary J. Stelman, Jayme A. Morgan, Kelli S. Zeigler, Leonard M. Azzarano, Jonathan R. Kehler, Jeanelle E. McSurdy-Freed, Joel W. Proksch and Brian R. SmithDrug Metabolism and Disposition February 2004, 32 (2) 172-177; DOI: https://doi.org/10.1124/dmd.32.2.172
Morgan, Paul
- You have accessNONLINEAR ORAL PHARMACOKINETICS OF THE α-ANTAGONIST 4-AMINO-5-(4-FLUOROPHENYL)-6,7-DIMETHOXY-2-[4-(MORPHOLINOCARBONYL)-PERHYDRO-1,4-DIAZEPIN-1-YL]QUINOLINE IN HUMANS: USE OF PRECLINICAL DATA TO RATIONALIZE CLINICAL OBSERVATIONSAnthony Harrison, Alison Betts, Katherine Fenner, Kevin Beaumont, Alan Edgington, Sarah Roffey, John Davis, Pierre Comby and Paul MorganDrug Metabolism and Disposition February 2004, 32 (2) 197-204; DOI: https://doi.org/10.1124/dmd.32.2.197
N
Nagao, Akihiko
- You have accessBIOTRANSFORMATION OF FUCOXANTHINOL INTO AMAROUCIAXANTHIN A IN MICE AND HEPG2 CELLS: FORMATION AND CYTOTOXICITY OF FUCOXANTHIN METABOLITESAkira Asai, Tatsuya Sugawara, Hiroshi Ono and Akihiko NagaoDrug Metabolism and Disposition February 2004, 32 (2) 205-211; DOI: https://doi.org/10.1124/dmd.32.2.205
Nikolic, Dejan
- You have accessMETABOLISM OF 8-PRENYLNARINGENIN, A POTENT PHYTOESTROGEN FROM HOPS (HUMULUS LUPULUS), BY HUMAN LIVER MICROSOMESDejan Nikolic, Yongmei Li, Lucas R. Chadwick, Simonida Grubjesic, Pia Schwab, Peter Metz and Richard B. van BreemenDrug Metabolism and Disposition February 2004, 32 (2) 272-279; DOI: https://doi.org/10.1124/dmd.32.2.272
O
Ohno, Akiko
- You have accessINVOLVEMENT OF HUMAN HEPATIC UGT1A1, UGT2B4, AND UGT2B7 IN THE GLUCURONIDATION OF CARVEDILOLAkiko Ohno, Yoshiro Saito, Nobumitsu Hanioka, Hideto Jinno, Mayumi Saeki, Masanori Ando, Shogo Ozawa and Jun-ichi SawadaDrug Metabolism and Disposition February 2004, 32 (2) 235-239; DOI: https://doi.org/10.1124/dmd.32.2.235
Ono, Hiroshi
- You have accessBIOTRANSFORMATION OF FUCOXANTHINOL INTO AMAROUCIAXANTHIN A IN MICE AND HEPG2 CELLS: FORMATION AND CYTOTOXICITY OF FUCOXANTHIN METABOLITESAkira Asai, Tatsuya Sugawara, Hiroshi Ono and Akihiko NagaoDrug Metabolism and Disposition February 2004, 32 (2) 205-211; DOI: https://doi.org/10.1124/dmd.32.2.205
Ozawa, Shogo
- You have accessINVOLVEMENT OF HUMAN HEPATIC UGT1A1, UGT2B4, AND UGT2B7 IN THE GLUCURONIDATION OF CARVEDILOLAkiko Ohno, Yoshiro Saito, Nobumitsu Hanioka, Hideto Jinno, Mayumi Saeki, Masanori Ando, Shogo Ozawa and Jun-ichi SawadaDrug Metabolism and Disposition February 2004, 32 (2) 235-239; DOI: https://doi.org/10.1124/dmd.32.2.235
P
Patrick, James E.
- You have accessIDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF POSACONAZOLE (NOXAFIL)Anima Ghosal, Neil Hapangama, Yuan Yuan, Joana Achanfuo-Yeboah, Robert Iannucci, Swapan Chowdhury, Kevin Alton, James E. Patrick and Shmuel ZbaidaDrug Metabolism and Disposition February 2004, 32 (2) 267-271; DOI: https://doi.org/10.1124/dmd.32.2.267
Proksch, Joel W.
- You have accessDEVELOPMENT OF AN IN VIVO PRECLINICAL SCREEN MODEL TO ESTIMATE ABSORPTION AND FIRST-PASS HEPATIC EXTRACTION OF XENOBIOTICS. II. USE OF KETOCONAZOLE TO IDENTIFY P-GLYCOPROTEIN/CYP3A-LIMITED BIOAVAILABILITY IN THE MONKEYKeith W. Ward, Gary J. Stelman, Jayme A. Morgan, Kelli S. Zeigler, Leonard M. Azzarano, Jonathan R. Kehler, Jeanelle E. McSurdy-Freed, Joel W. Proksch and Brian R. SmithDrug Metabolism and Disposition February 2004, 32 (2) 172-177; DOI: https://doi.org/10.1124/dmd.32.2.172
Purchio, Anthony F.
- You have accessDIFFERENTIAL REGULATION OF THE HUMAN CYP3A4 PROMOTER IN TRANSGENIC MICE AND RATSWeisheng Zhang, Anthony F. Purchio, Richard Coffee and David B. WestDrug Metabolism and Disposition February 2004, 32 (2) 163-167; DOI: https://doi.org/10.1124/dmd.32.2.163
R
Reguiga, Makram Ben
- You have accessEFFECT OF RECOMBINANT INTERLEUKIN-2 PRETREATMENT ON ORAL AND INTRAVENOUS DIGOXIN PHARMACOKINETICS AND P-GLYCOPROTEIN ACTIVITY IN MICEVincent Castagne, Laurence Bonhomme-Faivre, Saik Urien, Makram Ben Reguiga, Mireille Soursac, Francois Gimenez and Robert FarinottiDrug Metabolism and Disposition February 2004, 32 (2) 168-171; DOI: https://doi.org/10.1124/dmd.32.2.168
Riggs, K. Wayne
- You have accessSTEREOSELECTIVE PHARMACOKINETICS OF FLUOXETINE AND NORFLUOXETINE ENANTIOMERS IN PREGNANT SHEEPJohn Kim, K. Wayne Riggs and Dan W. RurakDrug Metabolism and Disposition February 2004, 32 (2) 212-221; DOI: https://doi.org/10.1124/dmd.32.2.212
Robichaud, Albert J.
- You have accessTHE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGSSu-Er W. Huskey, Brian J. Dean, George A. Doss, Zhen Wang, Cornelis E.C.A. Hop, Reza Anari, Paul E. Finke, Albert J. Robichaud, Minghua Zhang, Bonnie Wang, John R. Strauss, Paul K. Cunningham, William P. Feeney, Ronald B. Franklin, Thomas A. Baillie and Shuet-Hing L. ChiuDrug Metabolism and Disposition February 2004, 32 (2) 246-258; DOI: https://doi.org/10.1124/dmd.32.2.246
Roffey, Sarah
- You have accessNONLINEAR ORAL PHARMACOKINETICS OF THE α-ANTAGONIST 4-AMINO-5-(4-FLUOROPHENYL)-6,7-DIMETHOXY-2-[4-(MORPHOLINOCARBONYL)-PERHYDRO-1,4-DIAZEPIN-1-YL]QUINOLINE IN HUMANS: USE OF PRECLINICAL DATA TO RATIONALIZE CLINICAL OBSERVATIONSAnthony Harrison, Alison Betts, Katherine Fenner, Kevin Beaumont, Alan Edgington, Sarah Roffey, John Davis, Pierre Comby and Paul MorganDrug Metabolism and Disposition February 2004, 32 (2) 197-204; DOI: https://doi.org/10.1124/dmd.32.2.197
Rurak, Dan W.
- You have accessSTEREOSELECTIVE PHARMACOKINETICS OF FLUOXETINE AND NORFLUOXETINE ENANTIOMERS IN PREGNANT SHEEPJohn Kim, K. Wayne Riggs and Dan W. RurakDrug Metabolism and Disposition February 2004, 32 (2) 212-221; DOI: https://doi.org/10.1124/dmd.32.2.212
S
Saeki, Mayumi
- You have accessINVOLVEMENT OF HUMAN HEPATIC UGT1A1, UGT2B4, AND UGT2B7 IN THE GLUCURONIDATION OF CARVEDILOLAkiko Ohno, Yoshiro Saito, Nobumitsu Hanioka, Hideto Jinno, Mayumi Saeki, Masanori Ando, Shogo Ozawa and Jun-ichi SawadaDrug Metabolism and Disposition February 2004, 32 (2) 235-239; DOI: https://doi.org/10.1124/dmd.32.2.235
Saito, Yoshiro
- You have accessINVOLVEMENT OF HUMAN HEPATIC UGT1A1, UGT2B4, AND UGT2B7 IN THE GLUCURONIDATION OF CARVEDILOLAkiko Ohno, Yoshiro Saito, Nobumitsu Hanioka, Hideto Jinno, Mayumi Saeki, Masanori Ando, Shogo Ozawa and Jun-ichi SawadaDrug Metabolism and Disposition February 2004, 32 (2) 235-239; DOI: https://doi.org/10.1124/dmd.32.2.235
Sawada, Jun-ichi
- You have accessINVOLVEMENT OF HUMAN HEPATIC UGT1A1, UGT2B4, AND UGT2B7 IN THE GLUCURONIDATION OF CARVEDILOLAkiko Ohno, Yoshiro Saito, Nobumitsu Hanioka, Hideto Jinno, Mayumi Saeki, Masanori Ando, Shogo Ozawa and Jun-ichi SawadaDrug Metabolism and Disposition February 2004, 32 (2) 235-239; DOI: https://doi.org/10.1124/dmd.32.2.235
Schwab, Pia
- You have accessMETABOLISM OF 8-PRENYLNARINGENIN, A POTENT PHYTOESTROGEN FROM HOPS (HUMULUS LUPULUS), BY HUMAN LIVER MICROSOMESDejan Nikolic, Yongmei Li, Lucas R. Chadwick, Simonida Grubjesic, Pia Schwab, Peter Metz and Richard B. van BreemenDrug Metabolism and Disposition February 2004, 32 (2) 272-279; DOI: https://doi.org/10.1124/dmd.32.2.272
Shen, Lixin
- You have accessDIFFERENTIAL ENANTIOSELECTIVITY AND PRODUCT-DEPENDENT ACTIVATION AND INHIBITION IN METABOLISM OF VERAPAMIL BY HUMAN CYP3ASLixin Shen, John F. Fitzloff and Chyung S. CookDrug Metabolism and Disposition February 2004, 32 (2) 186-196; DOI: https://doi.org/10.1124/dmd.32.2.186
Smith, Brian R.
- You have accessDEVELOPMENT OF AN IN VIVO PRECLINICAL SCREEN MODEL TO ESTIMATE ABSORPTION AND FIRST-PASS HEPATIC EXTRACTION OF XENOBIOTICS. II. USE OF KETOCONAZOLE TO IDENTIFY P-GLYCOPROTEIN/CYP3A-LIMITED BIOAVAILABILITY IN THE MONKEYKeith W. Ward, Gary J. Stelman, Jayme A. Morgan, Kelli S. Zeigler, Leonard M. Azzarano, Jonathan R. Kehler, Jeanelle E. McSurdy-Freed, Joel W. Proksch and Brian R. SmithDrug Metabolism and Disposition February 2004, 32 (2) 172-177; DOI: https://doi.org/10.1124/dmd.32.2.172
Soursac, Mireille
- You have accessEFFECT OF RECOMBINANT INTERLEUKIN-2 PRETREATMENT ON ORAL AND INTRAVENOUS DIGOXIN PHARMACOKINETICS AND P-GLYCOPROTEIN ACTIVITY IN MICEVincent Castagne, Laurence Bonhomme-Faivre, Saik Urien, Makram Ben Reguiga, Mireille Soursac, Francois Gimenez and Robert FarinottiDrug Metabolism and Disposition February 2004, 32 (2) 168-171; DOI: https://doi.org/10.1124/dmd.32.2.168
Stearns, Ralph A.
- You have accessIDENTIFICATION OF A HYDROXYLAMINE GLUCURONIDE METABOLITE OF AN ORAL HYPOGLYCEMIC AGENTRandall R. Miller, George A. Doss and Ralph A. StearnsDrug Metabolism and Disposition February 2004, 32 (2) 178-185; DOI: https://doi.org/10.1124/dmd.32.2.178
Stelman, Gary J.
- You have accessDEVELOPMENT OF AN IN VIVO PRECLINICAL SCREEN MODEL TO ESTIMATE ABSORPTION AND FIRST-PASS HEPATIC EXTRACTION OF XENOBIOTICS. II. USE OF KETOCONAZOLE TO IDENTIFY P-GLYCOPROTEIN/CYP3A-LIMITED BIOAVAILABILITY IN THE MONKEYKeith W. Ward, Gary J. Stelman, Jayme A. Morgan, Kelli S. Zeigler, Leonard M. Azzarano, Jonathan R. Kehler, Jeanelle E. McSurdy-Freed, Joel W. Proksch and Brian R. SmithDrug Metabolism and Disposition February 2004, 32 (2) 172-177; DOI: https://doi.org/10.1124/dmd.32.2.172
Strauss, John R.
- You have accessTHE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGSSu-Er W. Huskey, Brian J. Dean, George A. Doss, Zhen Wang, Cornelis E.C.A. Hop, Reza Anari, Paul E. Finke, Albert J. Robichaud, Minghua Zhang, Bonnie Wang, John R. Strauss, Paul K. Cunningham, William P. Feeney, Ronald B. Franklin, Thomas A. Baillie and Shuet-Hing L. ChiuDrug Metabolism and Disposition February 2004, 32 (2) 246-258; DOI: https://doi.org/10.1124/dmd.32.2.246
Sugawara, Tatsuya
- You have accessBIOTRANSFORMATION OF FUCOXANTHINOL INTO AMAROUCIAXANTHIN A IN MICE AND HEPG2 CELLS: FORMATION AND CYTOTOXICITY OF FUCOXANTHIN METABOLITESAkira Asai, Tatsuya Sugawara, Hiroshi Ono and Akihiko NagaoDrug Metabolism and Disposition February 2004, 32 (2) 205-211; DOI: https://doi.org/10.1124/dmd.32.2.205
T
Takakura, Yoshinobu
- You have accessAN EVALUATION METHOD FOR NONLINEAR LOCAL DISPOSITION IN RAT LIVER AND KIDNEYTakako Kato, Kiyoshi Yamaoka and Yoshinobu TakakuraDrug Metabolism and Disposition February 2004, 32 (2) 230-234; DOI: https://doi.org/10.1124/dmd.32.2.230
Terauchi, Yoshiaki
- You have accessPOLYMORPHIC EXPRESSION OF CYP1A2 LEADING TO INTERINDIVIDUAL VARIABILITY IN METABOLISM OF A NOVEL BENZODIAZEPINE RECEPTOR PARTIAL INVERSE AGONIST IN DOGSMasashi Mise, Seiji Yadera, Michiaki Matsuda, Takanori Hashizume, Satoshi Matsumoto, Yoshiaki Terauchi and Toshihiko FujiiDrug Metabolism and Disposition February 2004, 32 (2) 240-245; DOI: https://doi.org/10.1124/dmd.32.2.240
U
Urien, Saik
- You have accessEFFECT OF RECOMBINANT INTERLEUKIN-2 PRETREATMENT ON ORAL AND INTRAVENOUS DIGOXIN PHARMACOKINETICS AND P-GLYCOPROTEIN ACTIVITY IN MICEVincent Castagne, Laurence Bonhomme-Faivre, Saik Urien, Makram Ben Reguiga, Mireille Soursac, Francois Gimenez and Robert FarinottiDrug Metabolism and Disposition February 2004, 32 (2) 168-171; DOI: https://doi.org/10.1124/dmd.32.2.168
V
van Breemen, Richard B.
- You have accessMETABOLISM OF 8-PRENYLNARINGENIN, A POTENT PHYTOESTROGEN FROM HOPS (HUMULUS LUPULUS), BY HUMAN LIVER MICROSOMESDejan Nikolic, Yongmei Li, Lucas R. Chadwick, Simonida Grubjesic, Pia Schwab, Peter Metz and Richard B. van BreemenDrug Metabolism and Disposition February 2004, 32 (2) 272-279; DOI: https://doi.org/10.1124/dmd.32.2.272
W
Wang, Bonnie
- You have accessTHE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGSSu-Er W. Huskey, Brian J. Dean, George A. Doss, Zhen Wang, Cornelis E.C.A. Hop, Reza Anari, Paul E. Finke, Albert J. Robichaud, Minghua Zhang, Bonnie Wang, John R. Strauss, Paul K. Cunningham, William P. Feeney, Ronald B. Franklin, Thomas A. Baillie and Shuet-Hing L. ChiuDrug Metabolism and Disposition February 2004, 32 (2) 246-258; DOI: https://doi.org/10.1124/dmd.32.2.246
Wang, Ying-Hong
- You have accessPREDICTION OF CYTOCHROME P450 3A INHIBITION BY VERAPAMIL ENANTIOMERS AND THEIR METABOLITESYing-Hong Wang, David R. Jones and Stephen D. HallDrug Metabolism and Disposition February 2004, 32 (2) 259-266; DOI: https://doi.org/10.1124/dmd.32.2.259
Wang, Zhen
- You have accessTHE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGSSu-Er W. Huskey, Brian J. Dean, George A. Doss, Zhen Wang, Cornelis E.C.A. Hop, Reza Anari, Paul E. Finke, Albert J. Robichaud, Minghua Zhang, Bonnie Wang, John R. Strauss, Paul K. Cunningham, William P. Feeney, Ronald B. Franklin, Thomas A. Baillie and Shuet-Hing L. ChiuDrug Metabolism and Disposition February 2004, 32 (2) 246-258; DOI: https://doi.org/10.1124/dmd.32.2.246
Ward, Keith W.
- You have accessDEVELOPMENT OF AN IN VIVO PRECLINICAL SCREEN MODEL TO ESTIMATE ABSORPTION AND FIRST-PASS HEPATIC EXTRACTION OF XENOBIOTICS. II. USE OF KETOCONAZOLE TO IDENTIFY P-GLYCOPROTEIN/CYP3A-LIMITED BIOAVAILABILITY IN THE MONKEYKeith W. Ward, Gary J. Stelman, Jayme A. Morgan, Kelli S. Zeigler, Leonard M. Azzarano, Jonathan R. Kehler, Jeanelle E. McSurdy-Freed, Joel W. Proksch and Brian R. SmithDrug Metabolism and Disposition February 2004, 32 (2) 172-177; DOI: https://doi.org/10.1124/dmd.32.2.172
West, David B.
- You have accessDIFFERENTIAL REGULATION OF THE HUMAN CYP3A4 PROMOTER IN TRANSGENIC MICE AND RATSWeisheng Zhang, Anthony F. Purchio, Richard Coffee and David B. WestDrug Metabolism and Disposition February 2004, 32 (2) 163-167; DOI: https://doi.org/10.1124/dmd.32.2.163
Y
Yadera, Seiji
- You have accessPOLYMORPHIC EXPRESSION OF CYP1A2 LEADING TO INTERINDIVIDUAL VARIABILITY IN METABOLISM OF A NOVEL BENZODIAZEPINE RECEPTOR PARTIAL INVERSE AGONIST IN DOGSMasashi Mise, Seiji Yadera, Michiaki Matsuda, Takanori Hashizume, Satoshi Matsumoto, Yoshiaki Terauchi and Toshihiko FujiiDrug Metabolism and Disposition February 2004, 32 (2) 240-245; DOI: https://doi.org/10.1124/dmd.32.2.240
Yamaoka, Kiyoshi
- You have accessAN EVALUATION METHOD FOR NONLINEAR LOCAL DISPOSITION IN RAT LIVER AND KIDNEYTakako Kato, Kiyoshi Yamaoka and Yoshinobu TakakuraDrug Metabolism and Disposition February 2004, 32 (2) 230-234; DOI: https://doi.org/10.1124/dmd.32.2.230
Yuan, Yuan
- You have accessIDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF POSACONAZOLE (NOXAFIL)Anima Ghosal, Neil Hapangama, Yuan Yuan, Joana Achanfuo-Yeboah, Robert Iannucci, Swapan Chowdhury, Kevin Alton, James E. Patrick and Shmuel ZbaidaDrug Metabolism and Disposition February 2004, 32 (2) 267-271; DOI: https://doi.org/10.1124/dmd.32.2.267
Z
Zbaida, Shmuel
- You have accessIDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF POSACONAZOLE (NOXAFIL)Anima Ghosal, Neil Hapangama, Yuan Yuan, Joana Achanfuo-Yeboah, Robert Iannucci, Swapan Chowdhury, Kevin Alton, James E. Patrick and Shmuel ZbaidaDrug Metabolism and Disposition February 2004, 32 (2) 267-271; DOI: https://doi.org/10.1124/dmd.32.2.267
Zeigler, Kelli S.
- You have accessDEVELOPMENT OF AN IN VIVO PRECLINICAL SCREEN MODEL TO ESTIMATE ABSORPTION AND FIRST-PASS HEPATIC EXTRACTION OF XENOBIOTICS. II. USE OF KETOCONAZOLE TO IDENTIFY P-GLYCOPROTEIN/CYP3A-LIMITED BIOAVAILABILITY IN THE MONKEYKeith W. Ward, Gary J. Stelman, Jayme A. Morgan, Kelli S. Zeigler, Leonard M. Azzarano, Jonathan R. Kehler, Jeanelle E. McSurdy-Freed, Joel W. Proksch and Brian R. SmithDrug Metabolism and Disposition February 2004, 32 (2) 172-177; DOI: https://doi.org/10.1124/dmd.32.2.172
Zhang, Minghua
- You have accessTHE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGSSu-Er W. Huskey, Brian J. Dean, George A. Doss, Zhen Wang, Cornelis E.C.A. Hop, Reza Anari, Paul E. Finke, Albert J. Robichaud, Minghua Zhang, Bonnie Wang, John R. Strauss, Paul K. Cunningham, William P. Feeney, Ronald B. Franklin, Thomas A. Baillie and Shuet-Hing L. ChiuDrug Metabolism and Disposition February 2004, 32 (2) 246-258; DOI: https://doi.org/10.1124/dmd.32.2.246
Zhang, Weisheng
- You have accessDIFFERENTIAL REGULATION OF THE HUMAN CYP3A4 PROMOTER IN TRANSGENIC MICE AND RATSWeisheng Zhang, Anthony F. Purchio, Richard Coffee and David B. WestDrug Metabolism and Disposition February 2004, 32 (2) 163-167; DOI: https://doi.org/10.1124/dmd.32.2.163